HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
BSX
Boston Scientific Corp
Healthcare Medical Devices · Massachusetts, USA · Reports in usd
Market Cap: $80.03B
Market Cap
$80.03B
Enterprise Val
$89.60B
P/E Ratio
22.45
P/B Ratio
3.09
Trailing PEG (1Y)
0.23
As Of
May 7, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$26.10B
Gross Margin69.44%
Profit Margin69.44%
Return on Equity14.87%
Return on Assets8.28%
Current Ratio1.90
Debt/Equity0.43
LT Debt/Equity0.42
Revenue Per Share3.51

Income Statement

Mar 31, 2026
Revenue$5.20B
Cost of Revenue$1.59B
Gross Profit$3.61B
R&D$516.0M
SG&A$1.78B
Operating Expenses$2.51B
Operating Income$1.10B
Interest Expense$90.0M
Tax Expense-$176.0M
Net Income$1.34B
EPS (Basic)$0.90
EPS (Diluted)$0.90
EBIT$1.26B
EBITDA$1.61B
Consolidated Income$1.34B
Non-Controlling Interests-$2.0M

Balance Sheet

Mar 31, 2026
Cash & Equivalents$1.45B
Accounts Receivable$3.03B
Inventory$3.12B
Current Assets$8.68B
LT Investments$0.00
Property, Plant & Equipment$4.06B
Intangibles$25.60B
Non-Current Assets$35.67B
Total Assets$44.35B
Accounts Payable$1.14B
Current Debt$41.0M
Current Liabilities$4.57B
LT Debt$10.99B
Non-Current Liabilities$13.68B
Total Liabilities$18.25B
Total Debt$11.03B
Retained Earnings$6.91B
Shareholder Equity$25.86B
Shares Outstanding1,483,885,456

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$348.0M
Investing Cash Flow-$591.0M
Financing Cash Flow-$260.0M
CapEx-$177.0M
Free Cash Flow$171.0M
Depreciation & Amort.$351.0M
Stock-Based Comp$83.0M
Acquisitions / Disposals-$462.0M
Investment Activity$0.00
Debt Issued/Repaid-$259.0M
Equity Issued/Repaid-$4.0M
Dividends Paid$0.00
Net Change in Cash-$504.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h